Background Respiratory syncytial virus (RSV)‐associated acute respiratory infection (ARI) is
an underrecognized cause of illness in older adults. We conducted a systematic literature …

Respiratory syncytial virus (RSV) infection is a significant cause of hospitalization of children
in North America and one of the leading causes of death of infants less than 1 year of age …

Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory
infection, lower respiratory tract disease, clinical complications, and death in older adults …

Nirsevimab is an extended half-life monoclonal antibody specific for the prefusion
conformation of the respiratory syncytial virus (RSV) F protein, which has been studied in …

Background Although human respiratory syncytial virus (RSV) is an important cause of
illness and death in older adults, no RSV vaccine has been licensed. Methods In a phase 2a …

Nationwide prospective surveillance of all-age patients with acute respiratory infections was
conducted in China between 2009‒2019. Here we report the etiological and …

Viral infections are dangerous diseases for human health worldwide, which lead to
significant morbidity and mortality each year. Because of their importance and the lack of …

Background The aim of this study was to investigate safety and immunogenicity of vaccine
formulations against respiratory syncytial virus (RSV) containing the stabilized prefusion …

Human respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae
family, Orthopneumovirus genus. It is a negative sense, single stranded RNA virus that …

Abstract The International Society for Influenza and other Respiratory Virus Diseases held its
6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13–15, 2018 …